May C.M. Yang

676 total citations
32 papers, 573 citations indexed

About

May C.M. Yang is a scholar working on Hepatology, Epidemiology and Physiology. According to data from OpenAlex, May C.M. Yang has authored 32 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 11 papers in Epidemiology and 11 papers in Physiology. Recurrent topics in May C.M. Yang's work include Liver Disease and Transplantation (15 papers), Liver Disease Diagnosis and Treatment (10 papers) and Nitric Oxide and Endothelin Effects (6 papers). May C.M. Yang is often cited by papers focused on Liver Disease and Transplantation (15 papers), Liver Disease Diagnosis and Treatment (10 papers) and Nitric Oxide and Endothelin Effects (6 papers). May C.M. Yang collaborates with scholars based in Taiwan, United States and Canada. May C.M. Yang's co-authors include Peter K.T. Pang, Thomas E. Tenner, Han‐Chieh Lin, Alexander D. Kenny, Jon‐Son Kuo, Chieh-Fu Chen, Henry T. Keutmann, Chuang‐Ye Hong, Yang‐Te Tsai and Yi‐Tsau Huang and has published in prestigious journals such as Endocrinology, The Journal of Urology and Journal of Hepatology.

In The Last Decade

May C.M. Yang

32 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
May C.M. Yang Taiwan 15 196 165 153 93 88 32 573
C Hallbrucker Germany 17 373 1.9× 219 1.3× 231 1.5× 213 2.3× 324 3.7× 18 941
Emi Sasaki Japan 14 235 1.2× 69 0.4× 61 0.4× 83 0.9× 49 0.6× 28 548
Masayasu Inoue Japan 12 173 0.9× 75 0.5× 138 0.9× 58 0.6× 104 1.2× 14 509
Sura Wanessa Santos Rocha Brazil 14 204 1.0× 42 0.3× 140 0.9× 76 0.8× 43 0.5× 26 615
Lawrence Yoon United States 13 418 2.1× 78 0.5× 163 1.1× 150 1.6× 72 0.8× 26 829
Mohammed S. El‐Awady Egypt 16 135 0.7× 39 0.2× 89 0.6× 77 0.8× 46 0.5× 28 452
G Rudolph Germany 12 99 0.5× 122 0.7× 64 0.4× 109 1.2× 143 1.6× 43 600
Diptadip Dattaroy United States 16 304 1.6× 74 0.4× 123 0.8× 241 2.6× 190 2.2× 20 744
Alfred Lohninger Austria 11 219 1.1× 20 0.1× 165 1.1× 94 1.0× 48 0.5× 30 568
Helena Corominola Spain 13 189 1.0× 81 0.5× 230 1.5× 291 3.1× 157 1.8× 21 683

Countries citing papers authored by May C.M. Yang

Since Specialization
Citations

This map shows the geographic impact of May C.M. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May C.M. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May C.M. Yang more than expected).

Fields of papers citing papers by May C.M. Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May C.M. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May C.M. Yang. The network helps show where May C.M. Yang may publish in the future.

Co-authorship network of co-authors of May C.M. Yang

This figure shows the co-authorship network connecting the top 25 collaborators of May C.M. Yang. A scholar is included among the top collaborators of May C.M. Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with May C.M. Yang. May C.M. Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Han‐Chieh, May C.M. Yang, Yi‐Tsau Huang, et al.. (1997). The Hemodynamic Effects of AT-112, an Analog of Ketanserin, in Portal Hypertensive Rats. Pharmacology. 54(1). 16–23. 7 indexed citations
2.
Huang, Yi‐Tsau, et al.. (1997). Hemodynamic Effects of Chronic Tetrandrine and Propranolol Administration on Portal Hypertensive Rats. Pharmacology. 54(5). 225–231. 5 indexed citations
3.
Lin, Han‐Chieh, May C.M. Yang, FA‐YAUH LEE, et al.. (1996). Hyperglucagonaemia in cirrhotic patients and its relationship to the severity of cirrhosis and haemodynamic values. Journal of Gastroenterology and Hepatology. 11(5). 422–428. 12 indexed citations
4.
TSAI, YANG‐TE, et al.. (1996). Effect of octreotide on total effective vascular compliance in patients with posthepatitic cirrhosis. Journal of Hepatology. 24(1). 81–87. 14 indexed citations
5.
Huang, Yi‐Tsau, Han‐Chieh Lin, Fa‐Yauh Lee, et al.. (1996). Decreased vascular reactivity of portal vein in rats with portal hypertension. Journal of Hepatology. 24(2). 194–199. 8 indexed citations
6.
Huang, Yi‐Tsau, et al.. (1996). Chronic Administration of Octreotide Increases Vascular Responsiveness in Rats with Portal Hypertension. Clinical Science. 91(5). 601–606. 14 indexed citations
7.
Tsai, Yang‐Te, et al.. (1995). Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function. Journal of Hepatology. 23(6). 681–688. 49 indexed citations
8.
Yang, May C.M., et al.. (1995). Decreased vascular contractile and inositol phosphate responses in portal hypertensive rats. Canadian Journal of Physiology and Pharmacology. 73(3). 378–382. 13 indexed citations
9.
Lin, Han‐Chieh, et al.. (1995). Haemodynamic effects of a combination of propranolol and clonidine in patients with post‐hepatitic cirrhosis. Journal of Gastroenterology and Hepatology. 10(3). 281–286. 8 indexed citations
10.
Chen, Chieh-Fu, et al.. (1995). Fructus aurantii reduced portal pressure in portal hypertensive rats. Life Sciences. 57(22). 2011–2020. 48 indexed citations
11.
Huang, Yi‐Tsau, et al.. (1995). Change in Vascular cAMP and cGMP Contents in Portal Hypertensive Rats. Pharmacology. 50(2). 86–91. 17 indexed citations
12.
Cheng, Fu‐Chou, et al.. (1994). Rapid assay of the monoamine content in small volumes of rat plasma. Journal of Chromatography B Biomedical Sciences and Applications. 653(1). 9–16. 11 indexed citations
13.
Lin, Han‐Chieh, et al.. (1993). Effects of reserpine administration in two models of portal hypertension in rats. Journal of Hepatology. 19(3). 413–417. 5 indexed citations
14.
Kuo, J.S., et al.. (1992). Responsiveness to synthetic parathyroid hormone in the portal vein of portal hypertensive rats. Journal of Hepatology. 16(3). 326–331. 9 indexed citations
15.
Yang, May C.M., Shulin Wu, Jon‐Son Kuo, & Chieh-Fu Chen. (1990). The hypotensive and negative chronotropic effects of dehydroevodiamine. European Journal of Pharmacology. 182(3). 537–542. 32 indexed citations
16.
Yang, May C.M., Peter K.T. Pang, Chii‐Shyan Lay, et al.. (1990). Effect of parathyroid hormone on portal pressure in portal hypertensive rats. Liver International. 10(1). 11–16. 7 indexed citations
17.
Pang, Peter K.T., May C.M. Yang, & James S.K. Sham. (1988). Parathyroid hormone and calcium entry blockade in a vascular tissue. Life Sciences. 42(14). 1395–1400. 29 indexed citations
18.
Helwig, Jean‐Jacques, May C.M. Yang, C Bollack, C. Judes, & Peter K.T. Pang. (1987). Structure-activity relationship of parathyroid hormone: relative sensitivity of rabbit renal microvessel and tubule adenylate cyclases to oxidized PTH and PTH inhibitors. European Journal of Pharmacology. 140(3). 247–257. 15 indexed citations
19.
Pang, Peter K.T., et al.. (1984). Hypotensive action of parathyroid hormone in chicken. Journal of Experimental Zoology. 232(3). 691–696. 9 indexed citations
20.
Pang, Peter K.T., May C.M. Yang, & Hirofumi Sokabe. (1981). Effects of a converting enzyme inhibitor and angiotensin antagonists on the rat pressor effect of angiotensin-like substance formed by goosefish Stannius corpuscles and homologous plasma. General and Comparative Endocrinology. 45(3). 402–405. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Hallbrucker Breakdown of academic impact, for papers by Emi Sasaki Breakdown of academic impact, for papers by Masayasu Inoue Breakdown of academic impact, for papers by Sura Wanessa Santos Rocha Breakdown of academic impact, for papers by Lawrence Yoon Breakdown of academic impact, for papers by Mohammed S. El‐Awady Breakdown of academic impact, for papers by G Rudolph Breakdown of academic impact, for papers by Diptadip Dattaroy Breakdown of academic impact, for papers by Alfred Lohninger Breakdown of academic impact, for papers by Helena Corominola
Rankless by CCL
2026